Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial

Lancet Diabetes Endocrinol. 2023 Dec;11(12):894. doi: 10.1016/S2213-8587(23)00290-5.

Authors

Mirac Vural Keskinler¹, Ozge Telci Caklili², Aytekin Oguz³

Affiliations

¹ Department of Internal Medicine, Istanbul Medeniyet University, Istanbul 34722, Türkiye. Electronic address: [email protected].
² Department of Endocrinology, Kocaeli City Hospital, Kocaeli, Türkiye.
³ Department of Internal Medicine, Istanbul Medeniyet University, Istanbul 34722, Türkiye.

PMID: 37996194
DOI: 10.1016/S2213-8587(23)00290-5

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Clinical Trials as Topic
Diabetes Mellitus, Type 2* / drug therapy
Glucose*
Humans
Hypoglycemic Agents / therapeutic use

Substances

Glucose
Hypoglycemic Agents